Riskpilot← Back to searchSign inGet full accessMSProfylaksia Oy
OYDissolvedY-tunnus 2621002-2As. 8Medical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
EUR 207K
+9% vs 2023
EBITDA margin
60.6%
+11% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
EUR 100K
+11% vs 2023
| Revenue | EUR 207K | +9% |
| EBITDA | EUR 125K | +11% |
| Net profit | EUR 100K | +11% |
| Total assets | EUR 233K | +35% |
| Equity | EUR 220K | +28% |
| Employees | 1 | — |
Legal name
MSProfylaksia Oy
Y-tunnus number
2621002-2
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
12. toukokuuta 2014
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Terveyden- ja sairaanhoitopalvelut, jossa normaalia yleislääkärin, osa-aikaisen työterveyslääkärin ja jatkossa fysiatrian erikoislääkärin vastaanottotoimintaa. Lisäksi tarvittaessa oman alaan liittyvää koulutusta, luennointia ja ohjausta eri asiakkaille, esim. koulut, yhdistykset, seurat, yhteistyösairaalat.
Address
As. 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 82 | 120 | 70 | 56 | 189 | 207 |
| Staff expenses | −7 | −7 | −7 | −7 | −30 | −31 |
| EBITDA | 48 | 76 | 41 | 31 | 113 | 125 |
| Depreciation & amort. | — | — | — | — | −1 | −1 |
| EBIT | 48 | 76 | 41 | 31 | 113 | 125 |
| Net financials | 0 | — | −0 | 0 | −0 | 0 |
| Profit before tax | 48 | 76 | 41 | 31 | 113 | 125 |
| Tax | 10 | 15 | 8 | 6 | 23 | 25 |
| Net profit | 39 | 61 | 33 | 25 | 90 | 100 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 64 | 102 | 114 | 123 | 173 | 233 |
| Equity | 59 | 100 | 113 | 121 | 172 | 220 |
| Long-term debt | — | — | — | — | 0 | 0 |
| Short-term debt | 5 | 2 | 1 | 2 | 2 | 13 |
| Total debt | 5 | 2 | 1 | 2 | 2 | 13 |
EBITDA margin
60.6%
This company
15.8%
Market median
+284% vs market
20192024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20192024
Return on equity
45.3%
This company
18.4%
Market median
+146% vs market
20192024
Net profit margin
48.3%
This company
8.1%
Market median
+496% vs market
20192024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20192024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KJ Deputy Member | Deputy Member | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MSProfylaksia Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kai Juhani Pulkkinen | Deputy Member | 0 companies |
| Maria Susanna Vanhanen | Board of Directors | 0 companies |